Results 191 to 200 of about 203,299 (265)

Diagnostic, Prognostic, and Predictive Tissue Biomarkers in Urothelial Carcinoma In Situ: A Narrative Review. [PDF]

Diagnostics (Basel)
Sanguedolce F, Cormio A, Zanelli M, Zizzo M, Palicelli A, Falagario UG, Milanese G, Galosi AB, Mazzucchelli R, Cormio L, Carrieri G.   +10 more
europepmc   +1 more source

Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations

International Journal of Cancer, EarlyView.
Early detection of colorectal cancer via population‐based screening programs can reduce incidence and mortality, but current screening approaches are limited. This systematic review evaluated the screening potential of blood‐based circulating tumor DNA assays in asymptomatic screening populations.
Caroline Ledertoug Kahn, Maria Wissing Rasmussen, Jakob Kleif, Inge Søkilde Pedersen, Christina Therkildsen   +4 more
wiley   +1 more source

Race-related subsequent breast events after ductal carcinoma in situ: A Surveillance, Epidemiology, and End Results-based analysis. [PDF]

Cancer
Koric A, Jiang S, Liu Y, Colditz GA.
europepmc   +1 more source

Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark

International Journal of Cancer, EarlyView.
Uncertainty has persisted over whether human papillomavirus (HPV) testing outperforms high‐quality cytology in real‐world cervical cancer screening programs. To address this, Denmark launched a nationwide trial in 2021, implementing an HPV‐based screening strategy using specialized algorithms integrated with molecular and cytology triage to optimize ...
Jesper Bonde, Jeppe Bennekou Schroll, Birgitte Tønnes Pedersen, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Nielsen, Doris Schledermann, Bettina Kjær Kristensen, Berit Andersen, on behalf of the National Danish Cervical Cancer Screening Steering Committee   +12 more
wiley   +1 more source

Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast. [PDF]

Breast Cancer Res Treat
Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA.   +6 more
europepmc   +1 more source

Urothelial carcinoma in situ of the entire urinary tract with invasion into seminal vesicle: A case report. [PDF]

Urol Case Rep
Hsu VW, Swarbrick N, Kulkarni H, Redfern A, Hawks C, Picardo A, McCombie SP, Hayne D.   +7 more
europepmc   +1 more source

Integration of eQTL and GEO Datasets to Identify Genes Associated with Breast Ductal Carcinoma In Situ. [PDF]

Curr Issues Mol Biol
Mo CQ, Xie RW, Li WW, Zhong MJ, Li YY, Lin JY, Zhang JS, Zheng SK, Lin W, Kong LJ, Xu SW, Chen XJ.   +11 more
europepmc   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC). [PDF]

Int J Cancer
Näsman T, Birgersson M, Marklund L, Näsman A.   +3 more
europepmc   +1 more source

Quality of Life Among Patients With Ductal Carcinoma In Situ.

JAMA Netw Open
Dunsmore VJ, Snyder BS, Gareen IF, Lehman CD, Khan SA, Romanoff J, Gatsonis C, Corsetti RL, Rahbar H, Spell DW, Han LK, Bumberry JR, Miller KD, Sparano JA, Comstock C, Park E, Wagner LI, Carlos RC.   +17 more
europepmc   +1 more source

Epigenetic regulation of breast ductal carcinoma in situ by miR-217 through DNMT1 and Hedgehog-GLI pathway. [PDF]

J Cell Commun Signal
Wang Z, Wu L, Lai S, Guo S, Pu C, Zhang L, Li X.   +6 more
europepmc   +1 more source